Sharp Therapeutics Corp.
SHRX.V
TSX
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.52M | -1.52M | -939.70K | -939.70K | -842.60K |
| Total Depreciation and Amortization | 25.30K | 25.30K | 26.20K | 26.20K | 31.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 640.40K | 640.40K | 384.80K | 384.80K | 280.10K |
| Change in Net Operating Assets | 227.40K | 227.40K | 63.20K | 63.20K | 16.50K |
| Cash from Operations | -624.50K | -624.50K | -465.50K | -465.50K | -515.10K |
| Capital Expenditure | -7.20K | -7.20K | 0.00 | 0.00 | -5.20K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -7.20K | -7.20K | 0.00 | 0.00 | -5.20K |
| Total Debt Issued | 625.00K | 625.00K | -641.10K | -641.10K | 641.10K |
| Total Debt Repaid | -50.00K | -50.00K | -50.00K | -50.00K | -50.00K |
| Issuance of Common Stock | -- | -- | 1.19M | 1.19M | 1.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -14.80K | -14.80K | -- | -- | -- |
| Cash from Financing | 560.20K | 560.20K | 500.00K | 500.00K | 592.10K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -71.50K | -71.50K | 34.50K | 34.50K | 71.80K |